# OnCo record paper-checkmate-214-nejm-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-214-nejm-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-214-nejm-2018" ;
  schema:name "CheckMate 214: nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma"@en ;
  schema:description "Dual immunotherapy with nivolumab and ipilimumab lengthened survival compared with sunitinib in intermediate- and poor-risk advanced kidney cancer, with about one in ten patients achieving a complete response that has proved durable over years."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-214-nejm-2018/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1712126>, <https://pubmed.ncbi.nlm.nih.gov/29562145/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1712126> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Motzer RJ, Tannir NM, McDermott DF, et al." ;
  onco:cancers <https://onco.cc/cancers/clear-cell-rcc/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/sunitinib/> ;
  onco:trials <https://onco.cc/trials/checkmate-214/> ;
  onco:journals <https://onco.cc/journals/nejm/> .